Sulfadoxine+Pyrimethamine GMP Tablet Sulfadoxine500mg+Pyrimethamine25mg GMP

China Sulfadoxine+Pyrimethamine GMP Tablet Sulfadoxine500mg+Pyrimethamine25mg GMP, Find details about China Sulphadoxine, Sulfadimoxine from Sulfadoxine+Pyrimethamine GMP Tablet Sulfadoxine500mg+Pyrimethamine25mg GMP

Pharmaceutical Technology
Chemical Synthesis
Standard
B.P./USP
Packaging
3tabs/Blister
Storage
Dry Cool Place
Trademark
OEM
Specification
Sulfadoxine500mg+Pyrimethamine25mg
Origin
China
Pharmaceutical Technology
Chemical Synthesis
Standard
B.P./USP
Packaging
3tabs/Blister
Storage
Dry Cool Place
Trademark
OEM
Specification
Sulfadoxine500mg+Pyrimethamine25mg
Origin
China
Product name:Sulfadoxine+Pyrimethamine Tablet
Category: Tablet
Package: Sulfadoxine500mg+Pyrimethamine25mg *3tabs/blister
Brand:OEM/GMP
Packaging details:As usual, we also can make as your requirement. 

l nephritis, BUN and serum creatinine elevation, toxic nephrosis with oliguria and anuria, and crystalluria.
Drug fever, chills, periarteritis nodosa and LE phenomenon have occurred.
Contra-indications:
Repeated prophylactic (prolonged) use in patients with severe renal or hepatic failure, or blood dyscrasias; documented megaloblastic anemia caused by folate deficiency; use in infants younger than 2 mo of age; prophylactic use in pregnancy at term and during lactation; hypersensitivity to pyrimethamine, sulfonamides, or any other ingredient of sulfadoxine/pyrimethamine.
Warning:
Fatalities associated with the administration of sulfonamides, although rare, have occurred due to severe reactions, including fulminant hepatic necrosis, agranulocytosis, aplastic anemia and other blood dyscrasias. Fansidar (sulfadoxine and pyrimethamine) prophylactic regimen has been reported to cause leukopenia during a treatment of 2 months or longer. This leukopenia is generally mild and reversible.
Precautions:
Oral Sulfadoxine and Pyrimethamine has not been evaluated for the treatment of cerebral malaria or other severe manifestations of complicated malaria, including hyperparasitemia, pulmonary edema or renal failure. Patients with severe malaria are not candidates for oral therapy. In the event of recrudescent P. falciparum infections after treatment with Fansidar (sulfadoxine and pyrimethamine) or failure of chemoprophylaxis with Fansidar (sulfadoxine and pyrimethamine) , patients should be treated with a different blood schizonticide.
Sulfadoxine and Pyrimethamine should be given with caution to patients with impaired renal or hepatic function, to those with possible folate deficiency and to those with severe allergy or bronchial asthma. As with some sulfonamide drugs, in glucose-6-phosphate dehydrogenase-deficient individuals, hemolysis may occur. Urinalysis with microscopic examination and renal function tests should be performed during therapy of those patients who have impaired renal function. Excessive sun exposure should be avoided.
Storage instructions:
Store below 25ºC. Protect from moisture and light. Keep out of reach of children.
Sulfadoxine+Pyrimethamine GMP Tablet Sulfadoxine500mg+Pyrimethamine25mg GMP